147 related articles for article (PubMed ID: 18725905)
1. New-onset diabetes in an obese adolescent: diagnostic dilemmas.
Gerhardt CM; Klingensmith GJ
Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):578-83. PubMed ID: 18725905
[TBL] [Abstract][Full Text] [Related]
2. Onset of type 1 diabetes mellitus in two patients with maturity onset diabetes of the young.
Maltoni G; Zucchini S; Scipione M; Mantovani V; Salardi S; Cicognani A
Pediatr Diabetes; 2012 Mar; 13(2):208-12. PubMed ID: 21696527
[TBL] [Abstract][Full Text] [Related]
3. Ketosis-prone diabetes mellitus in an obese adolescent: A case report.
Tan H; Wang C; Yu Y
Medicine (Baltimore); 2019 Jun; 98(25):e16076. PubMed ID: 31232947
[TBL] [Abstract][Full Text] [Related]
4. Ketosis-resistant diabetes: a rare case in unlikely territory.
Wachira JK; Bhatia V
S D Med; 2013 Mar; 66(3):95, 97-9. PubMed ID: 23544296
[TBL] [Abstract][Full Text] [Related]
5. Hyperglycemic hyperosmolar state in an adolescent with type 1 diabetes mellitus.
Watanabe S; Kido J; Ogata M; Nakamura K; Mizukami T
Endocrinol Diabetes Metab Case Rep; 2019 Mar; 2019():. PubMed ID: 30836328
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of a young Japanese woman having marked obesity and abrupt onset of diabetes mellitus with ketoacidosis.
Kobayashi J; Sasaki T; Ishiba Y; Watanabe M
Diabetes Res Clin Pract; 2002 Dec; 58(3):167-72. PubMed ID: 12413775
[TBL] [Abstract][Full Text] [Related]
7. [Diabetes mellitus, but which type?].
Hoekstra JB; de Koning EJ
Ned Tijdschr Geneeskd; 2004 Apr; 148(16):761-4. PubMed ID: 15129562
[TBL] [Abstract][Full Text] [Related]
8. Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes.
Juneja R; Hirsch IB; Naik RG; Brooks-Worrell BM; Greenbaum CJ; Palmer JP
Metabolism; 2001 Sep; 50(9):1008-13. PubMed ID: 11555830
[TBL] [Abstract][Full Text] [Related]
9. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
[TBL] [Abstract][Full Text] [Related]
10. Eruptive xanthomas in a patient with soft-drink diabetic ketosis and apolipoprotein E4/2.
Tsuchiya S; Sawada S; Takeda K; Takahashi K; Nakajima T; Kohata M; Kurosawa S; Satake C; Imai J; Kikuchi K; Aiba S; Katagiri H
Endocr J; 2019 Jan; 66(1):107-114. PubMed ID: 30393272
[TBL] [Abstract][Full Text] [Related]
11. [Factors affecting C-peptide level during the first year of type 1 diabetes in children].
Zmysłowska A; Szadkowska A; Andrzejewski W; Wegner O; Wyka K; Młynarski W; Bodalski J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):103-11. PubMed ID: 15504313
[TBL] [Abstract][Full Text] [Related]
12. Adult-onset autoimmune diabetes identified by glutamic acid decarboxylase autoantibodies: a retrospective cohort study.
Wada E; Onoue T; Kinoshita T; Hayase A; Handa T; Ito M; Furukawa M; Okuji T; Kobayashi T; Iwama S; Sugiyama M; Takagi H; Hagiwara D; Suga H; Banno R; Goto M; Arima H
Diabetologia; 2021 Oct; 64(10):2183-2192. PubMed ID: 34268631
[TBL] [Abstract][Full Text] [Related]
13. Type 1 diabetes in insulin-treated adult-onset diabetic subjects.
Willis J; Scott R; Brown L; Zimmet P; MacKay I; Rowley M
Diabetes Res Clin Pract; 1998 Oct; 42(1):49-53. PubMed ID: 9884033
[TBL] [Abstract][Full Text] [Related]
14. Report of the committee on the classification and diagnostic criteria of diabetes mellitus.
; Seino Y; Nanjo K; Tajima N; Kadowaki T; Kashiwagi A; Araki E; Ito C; Inagaki N; Iwamoto Y; Kasuga M; Hanafusa T; Haneda M; Ueki K
J Diabetes Investig; 2010 Oct; 1(5):212-28. PubMed ID: 24843435
[TBL] [Abstract][Full Text] [Related]
15. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency.
Zimmet PZ; Tuomi T; Mackay IR; Rowley MJ; Knowles W; Cohen M; Lang DA
Diabet Med; 1994 Apr; 11(3):299-303. PubMed ID: 8033530
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic type 1 diabetes in Dallas, Texas: a 5-year experience.
Piñero-Piloña A; Litonjua P; Aviles-Santa L; Raskin P
Diabetes Care; 2001 Jun; 24(6):1014-8. PubMed ID: 11375362
[TBL] [Abstract][Full Text] [Related]
17. GAD autoantibodies in a selection-free population of insulin-treated diabetic patients: indicator of a high prevalence of LADA?
Schiel R; Müller UA
Diabetes Res Clin Pract; 2000 Jul; 49(1):33-40. PubMed ID: 10808061
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial.
Kelley DE; Bray GA; Pi-Sunyer FX; Klein S; Hill J; Miles J; Hollander P
Diabetes Care; 2002 Jun; 25(6):1033-41. PubMed ID: 12032111
[TBL] [Abstract][Full Text] [Related]
19. [Clinical characteristics and outcome of adult diabetic patients with ketosis as the initial manifestation: a follow-up study].
Cai XL; Ji LN
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 May; 16(5):299-302. PubMed ID: 15132798
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type 1 diabetes mellitus: frequency and segregation by age and gender.
Zimmet PZ; Elliott RB; Mackay IR; Tuomi T; Rowley MJ; Pilcher CC; Knowles WJ
Diabet Med; 1994 Nov; 11(9):866-71. PubMed ID: 7705024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
